Overview

Lewy body dementia, also known as LBD, is the second most common type of dementia after Alzheimer's disease. Protein deposits called Lewy bodies develop in nerve cells in the brain. The protein deposits affect brain regions involved in thinking, memory and movement. There are two forms of LBD that cause cognitive symptoms — dementia with Lewy bodies and Parkinson's disease dementia.

Lewy body dementia causes a decline in mental abilities that gradually gets worse over time. People with LBD might see things that aren't there, known as visual hallucinations. They also may have changes in alertness and attention.

People with Lewy body dementia commonly have symptoms of Parkinson's disease. These symptoms might include rigid muscles, slow movement, trouble walking and tremors.

Symptoms

Lewy body dementia symptoms can include:

  • Visual hallucinations. Seeing things that aren't there, known as hallucinations, might be one of the first symptoms of Lewy body dementia. This symptom often occurs regularly and may include seeing shapes, animals or people that aren't there. Hallucinations involving sounds, smells or touch are possible.
  • Movement symptoms. Signs of Parkinson's disease may occur. These symptoms include slowed movement, rigid muscles, tremor or a shuffling walk. This can cause the person to fall.
  • Poor regulation of body functions. The part of the nervous system that controls automatic functions is called the autonomic nervous system. Lewy body dementia can affect how well the autonomic nervous system controls blood pressure, heart rate, sweating and digestion. This can result in sudden drops in blood pressure upon standing, dizziness, falls, loss of bladder control and bowel issues such as constipation.
  • Cognitive changes. People with Lewy body dementia might have changes in thinking that are similar to symptoms of Alzheimer's disease. These symptoms may include confusion, poor attention, visual-spatial problems and memory loss.
  • Trouble with sleep. People with Lewy body dementia can have rapid eye movement, also known as REM sleep behavior disorder. This disorder causes people to physically act out their dreams while asleep. People with REM sleep behavior disorder may punch, kick, yell or scream while sleeping.
  • Varying attention. Episodes of drowsiness, long periods of staring into space, long naps during the day or disorganized speech are possible.
  • Depression or apathy. People with Lewy body dementia might develop depression or lose motivation.

From Mayo Clinic to your inbox

Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing health. Click here for an email preview.

We use the data you provide to deliver you the content you requested. To provide you with the most relevant and helpful information, we may combine your email and website data with other information we have about you. If you are a Mayo Clinic patient, we will only use your protected health information as outlined in our Notice of Privacy Practices. You may opt out of email communications at any time by clicking on the unsubscribe link in the email.

Causes

In people with Lewy body dementia, there's a buildup of proteins known as Lewy bodies. This protein also is associated with Parkinson's disease. People who have Lewy bodies in their brains also can have the plaques and tangles associated with Alzheimer's disease.

Risk factors

A few factors seem to increase the risk of developing Lewy body dementia, including:

  • Age. People older than 60 have a higher risk of getting the disease.
  • Sex. Lewy body dementia affects more men than women.
  • Family history. Those who have a family member with Lewy body dementia or Parkinson's disease are at greater risk.

Complications

Lewy body dementia is progressive. This means it gradually gets worse over time. As symptoms get worse, the disease can lead to:

  • Worsening dementia.
  • Aggressive behavior.
  • Depression.
  • Increased risk of falling and injury.
  • Worsening of movement symptoms, such as tremors.
  • Death, on average about 7 to 8 years after symptoms start.

June 21, 2025
  1. Lewy body dementia. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/Disorders/All-Disorders/Dementia-Lewy-Bodies-Information-Page. Accessed Feb. 22, 2025.
  2. McFarland N. Clinical features and diagnosis of dementia with Lewy bodies. https://www.uptodate.com/contents/search. Accessed Feb. 22, 2025.
  3. Budson AE, et al. Dementia with Lewy bodies. In: Memory Loss, Alzheimer's Disease, and Dementia. 3rd ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Feb. 22, 2025.
  4. Prasad S, et al. Recent advances in Lewy body dementia: A comprehensive review. Disease-a-Month. 2023; doi:10.1016/j.disamonth.2022.101441.
  5. Clinical management. Lewy Body Dementia Association. https://www.lbda.org/clinical-management/. Accessed Feb. 22, 2025.
  6. Understanding behavioral changes in dementia. Lewy Body Dementia Association. https://www.lbda.org/understanding-behavioral-changes-in-dementia/. Accessed Feb. 22, 2025.
  7. Galvin JE. Lewy body dementia. Continuum. 2024; doi:10.1212/CON.0000000000001496.
  8. Ferri FF. Dementia with Lewy bodies. In: Ferri's Clinical Advisor 2025. Elsevier; 2025. https://www.clinicalkey.com. Accessed Feb. 22, 2025.
  9. Press D. Management of neuropsychiatric symptoms of dementia. https://www.uptodate.com/search/contents. Accessed Feb. 22, 2025.
  10. Donaghy PC, et al. Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis. Alzheimer's & Dementia. 2023; doi:10.1002/alz.13105.
  11. Khan SA, et al. Insights into the management of Lewy body dementia: A scoping review. Annals of Medicine and Surgery. 2024; doi:10.1212/CON.0000000000001496.
  12. Luo G, et al. Effectiveness of non-pharmacological therapies on cognitive function in patients with dementia — A network meta-analysis of randomized controlled trials. Frontiers in Aging: Neuroscience. 2023; doi:10.3389/fnagi.2023.1131744.
  13. Dementia with Lewy bodies and Parkinson disease dementia. Merck Manual Professional Version. https://www.merckmanuals.com/professional/neurologic-disorders/delirium-and-dementia/dementia-with-lewy-bodies-and-parkinson-disease-dementia. Accessed Feb. 22, 2025.
  14. Nimmagadda R. Allscripts EPSi. Mayo Clinic. Dec. 24, 2024.
  15. Diphenhydramine oral. Facts & Comparisons eAnswers. https://fco.factsandcomparisons.com. Accessed March 2, 2025.
  16. Kobayashi S, et al Analysis of adverse events of cholinesterase inhibitors and NMDA receptor antagonists on arrhythmias using the Japanese Adverse Drug Event Report database. Drugs — Real World Outcomes. 2023; doi:10.1007/s40801-023-00362-6.
  17. Lewy body dementia: Causes, symptoms and diagnosis. National Institute on Aging. https://www.nia.nih.gov/health/lewy-body-dementia/lewy-body-dementia-causes-symptoms-and-diagnosis. Accessed Feb. 22, 2025.
  18. Compagnoni GM, et al. The role of 123-I-MIBG cardiac scintigraphy in the differential diagnosis between dementia with Lewy bodies and Alzheimer's disease. Neurological Sciences. 2024; doi:10.1007/s10072-024-07476-x.
  19. Arnold MR, et al. A-synuclein seed amplification in CSF and brain from patients with different brain distributions of pathological a-synuclein in the context of co-pathology and non-LBD diagnoses. Annals of Neurology. 2022; doi:10.1002/ana.26453.
  20. Gibbons CH, et al. Skin biopsy detection of phosphorylated a-synuclein in patients with synucleinopathies. JAMA. 2024; doi:10.1001/jama.2024.0792.